Ischemia
Postischemic vascular injury is limited by activation of A1 adenosine receptors
Published in Drug Week, June 16th, 2006
According to recent research from Australia, "This study evaluated the ability of A1 and A3 adenosine receptor (AR) agonism, and A1 ), A2A , A2B and A3 AR antagonism (revealing 'intrinsic' responses), to modify post-ischemic coronary dysfunction in mouse heart."
Griffith University-Southport investigators A.J. Zatta and colleagues wrote,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-06-16)
More Articles from Drug Week
- Cardiology
Acadesine reduces 2-year mortality following heart attacks in heart bypass patients - Drug Development
Acologix presents preclinical data on synthetic peptide - Drug Development
Axonyx completes multiple-dose phase I study of Posiphen - HIV/AIDS Drug Development
HIV-1 CD4 attachment inhibitor inhibits viral entry by altering envelope conformation - Sexual & Reproductive Health
ImQuest: Pyrimidinedione appears to prevent HIV transmission - Addiction Medicine
Bivalent morphine/heroin vaccine prevents relapse to heroin addiction - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
